Elinzanetant Meets All Endpoints in Phase 3 Study of VMS Caused by Adjuvant Endocrine Therapy for Breast Cancer
Elinzanetant produced a statistically significant reduction in frequency of treatment-related vasomotor symptoms as early as week 1 and in severity at weeks 4 and 12.
New Guidelines on Diagnosing Alzheimer’s Disease and Related Cognitive Impairments: A Comprehensive Framework for Primary Care
The first US interdisciplinary evaluation guideline will help primary care clinicians address the rising prevalence of AD and ADRD seen in their front-line clinical setting.
Mobile App Shows Promise for Hypertension Management: Daily Dose
Your daily dose of the clinical news you may have missed.
FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
FDA Proposes Sustained 5% Weight Loss to Establish Efficacy of New Antiobesity Medications
In an unusual step, the agency's draft guidance recommends the efficacy benchmark for drug approval while emphasizing clinical trial structure and cohort development.
FDA Grants Fast Track Designation to Posdinemab for Early Alzheimer's Disease
Johnson & Johnson's posdinemab aims to slow tau pathology in early and preclinical Alzheimer’s disease populations.
FDA OKs Tapinarof Cream, 1% for Atopic Dermatitis In Patients Aged 2 Years and Older: Daily Dose
Migraine Therapeutics Research that Made News with Neurologists in 2024: Interview with Peter McAllister, MD
Significant strides were made in 2024 in evaluating a wide range of treatments for migraine, including phase 2 findings with PACAP inhibition, PI McAllister said.
American College of Gastroenterology Releases Updated Guidelines for Eosinophilic Esophagitis
The updated guidelines include 19 recommendations related to the diagnosis and management of eosinophilic esophagitis.
9 Fast Fact about Avian Influenza for Primary Care
The bird flu threat remains low, according to public health authorities, but awareness and vigilance will help keep it that way. Here are 9 things you need to know.
Bird Flu: First US Death Reported, NIH Updates Risk Assessment
The first death of an American from the H5N1 virus was reported in Louisiana on Monday, though authorities maintain the risk of widespread infection remains low.
Prenatal Antibiotic Exposure Linked to Childhood Health Issues: Daily Dose
The Electrical Origins of Migraine May be Under the Microscope, Neurologist Peter McAllister, MD, Explains
The onset of migraine with its wide range of symptoms may be telegraphed as early as 2 days before by the frequency of neuronal oscillation deep in the brain.
Sanofi and SK Bioscience Expand Pneumococcal Vaccine Partnership, Launch Phase 3 Trial for PCV21
Sanofi and SK bioscience expand collaboration on pneumococcal conjugate vaccines, including a 21-valent candidate for pediatric populations.
Mediterranean Diet Ranked Best Diet Overall for 8th Consecutive Year
The 2025 rankings released by U.S. News & World Report featured 13 new diets and 12 new categories.
FDA Greenlights New Treatment for Moderate-to-Severe Atopic Dermatitis: Daily Dose
US Surgeon General: Add Cancer Warning to Alcoholic Beverage Labels
Murthy's advisory outlines evidence for the cancer-alcohol relationship and calls for greater efforts to increase public awareness of the risks from beer, wine, and spirits.
New Data Suggest Revised Colorectal Cancer Screening Guidelines Strain Community Health Centers
The USPSTF's revised CRC screening guidelines to include adults aged 45-49 years increased screening needs by about 23% without additional funding or resources for CHCs.
Neumora Therapeutics Reports Disappointing Results from Phase 3 Study of Navacaprant in MDD
The failure of the novel kappa opioid receptor antagonist to best placebo in the first of triplicate phase 3 studies has Neumora concerned but not deterred.
Mailed FIT Outreach Increases CRC Screening Rates: Daily Dose
